SequelSEC

Medinotec Inc. MDNC

Surgical & Medical Instruments & Apparatus · CIK 0001931055 · Fiscal year ends 0228

AnnualQuarterlyTTM
Revenue
$10.21M
Fiscal year ended 2026-08-31
Operating income
$672.08K
Fiscal year ended 2026-08-31
Free cash flow
Unavailable
Fiscal year ended 2026-08-31

Valuation, from the filing

Public float$9.16MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-08-31
Float per share$0.78Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / net income11.5×A lower bound on the multiple, because affiliate holdings are excluded.
Float / revenue0.9×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity1.6×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-08-31, not today, and each multiple below it uses the figures for the fiscal year ending 2026-02-28 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
CapEx / revenue0.0%0th
R&D / revenue1.5%5th
Effective tax rate-25.7%9th
Operating margin11.2%82th
Net margin8.2%81th
Current ratio5.83x80th
FCF margin9.3%79th
Gross margin52.7%32th
Revenue YoY growth6.8%32th

Medinotec Inc. (MDNC) reported revenue of $10.21M and net income of $597.03K for the fiscal year ended 2026-08-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Medinotec Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Medinotec Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-08-31
Revenue$10.21M
Cost of revenue$5.14M
Gross profit$5.07M
Operating income$672.08K
Net income$597.03K
Research & development$64.66K
Weighted-average diluted sharesUnavailable
Pretax income$658.34K
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$4.22M
General & administrative$2.45M
Selling & marketing$1.77M

Balance

Medinotec Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-08-31
Cash & equivalentsUnavailable
Total assets$6.95M
Current assets$6.44M
Total liabilities$1.02M
Current liabilities$955.28K
Total equity incl. NCI$5.93M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$2.62M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

Medinotec Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-08-31
Operating cash flow$373.90K
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flowUnavailable
Net change in cash$336.01K
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$108.98K

Derived

Medinotec Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-08-31
Free cash flowUnavailable
Gross margin49.6%
Operating margin6.6%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio6.74x
Revenue YoY growth-10.9%
Net margin5.8%
R&D / revenue0.6%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MDNC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-10-08View SEC filing
10-Q · Filed 2026-07-09View SEC filing
10-K · Filed 2026-05-28View SEC filing
10-Q · Filed 2026-01-09View SEC filing
10-Q · Filed 2025-10-08View SEC filing
10-Q · Filed 2025-07-16View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.